View Older Stories View More Recent Stories
-
UPDATE: BMO Capital Upgrades Coca-Cola (KO) to Outperform
-
Manulife completes Subordinated Debenture offering
-
UPDATE: BMO Capital Starts aTyr Pharma (LIFE) at Outperform
-
BMO Capital Upgrades PACCAR (PCAR) to Market Perform
-
BMO Capital Downgrades Arctic Cat (ACAT) to Underperform
-
BMO Bank of Montreal Partners With FreshBooks to Bring Leading Cloud-Based Accounting Software to Small Business Customers
-
Anglo Pacific Group PLC Director's Share Dealings
-
BMO Asset Management Announces Proposed Termination of Certain BMO Exchange Traded Funds
-
BMO Capital Maintains Outperform on Costco Wholesale (COST) Following 3Q Results
-
North American Financial 15 Split Corp. Announces Successful Overnight Offering
-
North American Financial 15 Split Corp. Announces Overnight Offering
-
Dividend 15 Split Corp. Completes Overnight Offering of $94,170,000
-
BMO Capital Downgrades First Potomac (FPO) to Market Perform
-
Dave & Buster's Entertainment, Inc. Announces Pricing of Secondary Offering of Common Stock
-
Dave & Buster's Entertainment, Inc. Announces Pricing of Secondary Offering of Common Stock
-
Manulife announces Subordinated Debenture issue
-
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Press Ganey Announces Closing of Initial Public Offering
-
Summer Internships: Strong Mutual Benefit to BMO and Student Participants
-
BMO Financial Group Reports Net Income of $1 Billion for the Second Quarter of 2015
-
Salesforce Executives to Participate in Upcoming Investor Events
-
Dave & Buster's Entertainment (PLAY) Announces 8.5M Common Secondary Offering
-
Dave & Buster's Entertainment, Inc. Announces Proposed Secondary Offering of Common Stock
-
Dave & Buster's Entertainment, Inc. Announces Proposed Secondary Offering of Common Stock
-
Stingray Digital Group Inc. Announces Pricing of Initial Public Offering
-
Anglo Pacific Group PLC Resignation of Executive Director and Chief Investment Officer
-
Warren Resources Announces Strategic Refinancing With Franklin Square Funds Sub-Advised by GSO Capital Partners LP
-
Warren Resources Announces Strategic Refinancing With Franklin Square Funds Sub-Advised by GSO Capital Partners LP
-
BMO Capital Starts PacWest Bancorp (PACW) at Outperform
-
BMO Capital Downgrades East West Bancorp (EWBC) to Market Perform
-
Ivanhoe Mines and China's Zijin Mining Group Sign Landmark Agreement to Co-Develop the World-Scale Kamoa Copper Discovery in the Democratic Republic of Congo
-
BMO Asset Management Inc. Announces an Index Change to BMO Emerging Markets Bond Hedged to CAD Index ETF
-
Fenix Parts Announces Exercise of Over-Allotment Option
-
Brocade (BRCD) Posts Another Storage Miss, BMO Capital Notes; EPS Estimates Lifted Despite Lower Revenues
-
BMO Capital Maintains Outperform on Zoetis (ZTS) Following Conference
-
New BMO CashBack World Elite MasterCard Maximizes CashBack on All Spending
-
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx
-
bluebird bio (BLUE) Demonstrates Strong Proof-of-Concept for LentiGlobin in SCD, BMO Capital Notes
-
BMO Announces $1 Million Donation to Stem Cell and Regenerative Medicine Research
-
Press Ganey Holdings (PGND) IPO Opens Up 11%
-
Fate Therapeutics (FATE) Prices 6M Common Offering at $5/Share
-
Fate Therapeutics Announces Pricing of Public Offering of Common Stock
-
Press Ganey Announces Pricing of Initial Public Offering
-
bluebird bio (BLUE) PT Raised to $200 at BMO Capital Ahead of SCD Data for LentiGlobin at EHA
-
Monsanto (MON) to Outline Corp. Trajectory at Annual AG Conference; Will Divest All Syngenta Seeds and Traits and Certain Overlapping Chemistry Assets
-
Monsanto Executive Addresses Investors at Annual AG Conference, Outlining Vision and Strategic Rationale for Integrated Agriculture Company and Providing Business Update
-
Green Plains to Present at the BMO Capital Markets 10th Annual Farm to Market Conference
-
Green Plains to Present at the BMO Capital Markets 10th Annual Farm to Market Conference
-
BMO Capital Says Buy Intercept Pharmaceuticals (ICPT) on Weakness Related to Trial Design

